Betaseron 0.3 MG kits
Ended Awarded Last action
- Contract number
- SPE2DR26F9V33
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,412
Award facts
- Contract value 100% obligated
- $83,412.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $83.4K delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract utilizing the company's existing indefinite delivery contract with DLA Troop Support Medical (valued at $1B through December 2026). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's parent organization is Cencora, Inc., which also holds a $1B IDC with DLA through December 2031 for comprehensive pharmaceutical and medical supply distribution.
This delivery order reflects the ongoing pharmaceutical support mission of DLA's Medical Supply Chain, which serves military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. Betaseron (interferon beta-1b) is a disease-modifying therapy commonly used in neurological treatment protocols. The non-competitive nature of this award—as a delivery order under an existing IDC—demonstrates AmerisourceBergen's established capability to efficiently fulfill government requirements for essential specialty pharmaceuticals and medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9V33?
SPE2DR26F9V33 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9V33 worth?
The government has obligated $83,412 on SPE2DR26F9V33.
Is contract SPE2DR26F9V33 an order under another contract?
Yes. SPE2DR26F9V33 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9V33 competed?
The extent of competition for SPE2DR26F9V33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award